arrow
M

Mehmet Kanbay

Koc University School of Medicine
H指数:71
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sodium-Glucose Cotransporter-2 inhibitor use during or after acute kidney injury and the risk of major adverse kidney events and Mortality: A systematic review and Meta-Analysis

钠-葡萄糖协同转运蛋白-2抑制剂在急性肾损伤期间或之后的使用与主要不良肾脏事件和死亡率风险:一项系统评价和Meta分析

2026-10-230
PRE
Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis

GLP-1受体激动剂和双重GIP/GLP-1受体激动剂对2型糖尿病中炎症和代谢生物标志物的影响:一项系统评价和Meta分析

2026-08-050
PRE
Kidney outcomes and safety of sodium-glucose cotransporter-2 inhibitor therapy in autosomal dominant polycystic kidney disease: systematic review and meta-analysis

钠-葡萄糖协同转运蛋白-2抑制剂疗法在常染色体显性多囊肾病中的肾脏结局与安全性:系统评价和Meta分析

2026-08-010
PRE
Heart-Type Fatty Acid–Binding Protein as a Marker of Subclinical Cardiac Dysfunction and Cardiorenal Interaction in Autosomal Dominant Polycystic Kidney Disease

心型脂肪酸结合蛋白作为常染色体显性多囊肾病患者亚临床心脏功能异常和心肾相互作用的标志物

Life
IF3.4
2026-06-080
OA
HFpEF Diagnosis: A Challenge in CKD with Current Algorithms

HFpEF诊断:慢性肾脏病患者中使用当前算法的挑战

Life
IF3.4
2026-06-030
OA
The evolving Field of Nephrology: What Comes Next? A report from the European Renal Association Scientific Advisory Board

肾脏病学领域的演变:未来将如何发展?——欧洲肾脏协会科学顾问委员会报告

2026-04-280
OA